Press Releases and Articles
|
| September 2008 |
Recap of 6th MarketReach America program:
MarketReach America
Life Sciences &
Medical Devices
2008
Here's a short report on MarketReach
America 2008, written by Tina Ornstein, CEO
of Trendlines International, just
after the conference in Baltimore
on September 11.
-
The poster session on Wednesday
afternoon was nicely done. Our
Israeli companies got some practice
networking in a friendly, non-threatening
environment.
- The reception/dinner
on Wednesday evening was also
very nice. A big turnout (close
to 200 people, including the Israeli
delegation), made serious conversations difficult, but the participating Israelis were impressed with the warmth and sincerity of the organizers, speakers, and guests.
- Today’s conference took place on the Johns Hopkins University campus. The auditorium
was full for the
company presentations,
which went very
well. We had a
lot of comments
that this was
an especially
strong delegation
and that the presentations
were on a high
level -- and Trendlines
got a lot of credit
for the work we
did in preparing
the companies.
- I think there were quite a few meaningful conversations for most of the Israeli companies. But it's possible that there will be other good stories in this department over the coming months.
- The one-on-one meetings with potential investors and strategic partners were lively. It seemed that the seeds were being planted for some interesting collaborations, but only time will tell.
- The two panels at the end of the day were both very informative. Lynn Shapiro Synder [Senior Member, Health Care and Life Sciences Practice, Epstein Becker & Green] moderated a panel that focused primarily on distribution, with the participation of the head of procurement and distribution at Johns Hopkins (the hospital and the university!) and a representative from Owens & Minor (who also met with a number of the companies during the one-on-one meetings). We all learned an incredible amount.
All in all, it was a good day and the Israeli participants were very complimentary about the quality of the organization -– both
in Israel and here in Maryland.
|
| October 2007 |
ETView reported to consider TASE IPO
The medical device firm hopes to raise $15 million.
Gali Weinreb, Globes[online]
(October 8, 2007)
Sources inform
Globes that ETView is currently
considering a TASE IPO, with
the aim of raising $15 million.
The offering would value the
firm at $30 million. While the
firm has not finalized its planned
offering process, it has already
started to put together the
prospectus. More ...
|
| September 2007 |
Israeli cell therapy could help PAD
sufferers walk again
By Nicky Blackburn, Israel21c (September 27, 2007)
When two middle-aged American men paid a visit to doctors at the University of
Michigan Medical Center in Ann Arbor, they could barely walk for more than five
to six minutes at a time. Instead they took part in a trial of a new form of
cell therapy developed by Israeli company, MultiGene
Vascular Systems (MGVS), and rather than lose a limb, both men are now up
and about, walking in a way they haven't managed for years. Read
the full story.
|
| June 2007 |
Red Herring and IVA to choose Israel's most promising
start-ups
The technology magazine will
hold an awards ceremony for Israeli companies.
Gali Weinreb and Shmulik Shelah, Globes[online] (June 6, 2007)
Multi-Gene Vascular Systems (MGVS)
was named as one of the finalists for 2007.
More ...
ETView looks to TASE IPO
The medical device company was shown on “ER”: “We’ve
reached the promised land.”
Gali Weinreb, Globes[online] (June 4, 2007)
Medical device start-up ETView Ltd. plans to raise $7-10 million in an IPO on
the Tel Aviv Stock Exchange (TASE). The company value for the offering has not
yet been set, nor have underwriters been chosen. More
...
|
| March 2007 |
First Patient Treated With MultiGeneAngio Novel Therapy
for Blocked Arteries
(BioIsrael, March 2007)
Last month at a Michigan hospital, a middle-aged American man, with blocked arteries
in his leg that could lead to leg amputation, became the first patient to be
treated with a new form of cell therapy that could restore mobility to him and
to hundreds of thousands of people suffering from blocked arteries. More...
|
| January 2007 |
MGVS begins phase I trials of blood vessel therapy
The company is due to obtain
FDA approval to begin Phase I trials of its second treatment,
MultiGeneAngio.
More ...
|
| May 2006 |
"Israeli healthcare cos to meet potential US partners"
MarketReach America will host
the Life Science & Medical Devices 2006 seminar and venture
conference in Baltimore in
June.
Globes[online] (May 7,
2006)
Business development program
MarketReach America, a partnership between the Maryland/Israel
Development Center and The
Trendlines Group, will host the Life Science & Medical
Devices 2006 seminar and venture conference in Baltimore, Maryland,
from June 19 to June 21.
Up to 20 selected Israeli life
science and medical device companies
will be tapped to introduce their products and technologies to strategic
partners and investors, and receive feedback on their US market
strategies from industry experts. The companies will have direct
exposure to business development executives from companies such
as Novation, Medtronic, MedImmune, and Bristol-Myers Squibb.
In addition,
the companies will pitch their
opportunity to angels, VC funds, and strategic
investors, all of whom have
a pre-qualified interest in
investing in Israeli companies.
Trendlines
managing director Tina Ornstein said, “The
MarketReach America program
connects some of Israel's
most promising life science
companies with strategic partners,
investors, and regulatory
authorities in the United
States. For companies looking
to initiate or increase their
activity in the United States,
MarketReach America provides
very cost-effective access
to the right audience."
Trendlines
is an Israeli international
marketing consulting and business
development firm.
The
Maryland/Israel Development
Center is a non-profit organization
promoting trade, joint ventures,
and investment between Maryland
and Israeli businesses and
research institutions. The
center was founded in 1988.
It is supported by the Maryland
Department of Business and
Economic Development, Israel’s
Ministry of Industry and Trade,
and The Jewish Community Federation
of Baltimore.
Other conference
sponsors include lawyers Epstein,
Becker & Green,
The Israel Export & International
Cooperation Institute, Israel
Life Science Industry, and
the Department of Business
and Economic Development of
the State of Maryland, and
intellectual property firms
Ellen B. Shankman & Associates
and Elandel Services Ltd.
|
| September 2005 |
"Chiasma raises $6.2m"
The medical start-up has developed
an innovative platform technology
for oral delivery of macromolecule
drugs.
Globes[online] (September 12,
2005)
Chiasma, Inc. a developer
of an innovative platform
technology for oral delivery
of macromolecule drugs, has
announced the completion of
a $6.2 million Series B financing
round.
Chiasma stated that it intends
to use these funds to advance
its lead therapeutic candidates
through clinical trials.
The investment round was co-led
by F-2 Ventures and the Ofer
Hi-Tech Group (the investment
arm of the Ofer Group), joined
by the InnoMed Fund (the life
science fund of Jerusalem
Global Ventures), and Yissum
Ltd., Technology Transfer
Company oft he Hebrew University
of Jerusalem. InnoMed funded the entire Series A round.
Chiasma is a MarketReach America Life Science
2004 company.
"Misgav incubator's ETView
raises $500,000"
ETView has developed an endotracheoscopic
ventilation tube equipped
with an embedded video camera.
Globes[online] (September
12, 2005)
ETView, a Misgav Technology Center graduate, has just raised its
first round of funding. The
start-up has raised $500,000
to date from private investors
in Israel and abroad.
ETView developed and produces
and endotracheoscopic ventilation
tube equipped with a miniature
video camera. The company
has taken an existing ventilation
tube used for artificial respiration
in patients, and by installing
a miniature video camera at
the tip of the tube, has developed
an innovative device. This
is the first respiration tube
developed to enable constant
visual observation of the
endotrachea during resuscitation
and throughout the entire
time that the patient is on
respiratory support (usually
in the intensive care unit).
ETView is a MarketReach America Life Science
2004 company.
|
 |
| April 2005 |
"Removing the Barriers in Homeland Security"
Excerpt
from The Jewish Week
SOME ISRAELI HOMELAND SECURITY FIRMS ARE SPREADING THE WORD AWAY
FROM THEIR HOME WITH HELP
FROM AMERICA
"The CEOs of five Israel-based
companies that produce homeland
security technologies are participating in a business development
program, sponsored in part by aerospace giant Lockheed Martin,
that seeks to help Israeli companies penetrate the American marketplace.
"The program, MarketReach America, is offering these businesses
hundreds of hours of consulting
and workshops, and provides them with individualized meetings with potential
customers and investors for a fee of less than $6,000.
"Israel leads the world in technological development,” said
Barry Bogage, executive director
of the Maryland/Israel Development Center, which runs MarketReach America in
cooperation with the business development company Trendlines Group, but the companies
often “stumble when it comes to developing their markets."
|
|
| March 2005 |
"Md. program designed to help Israel
homeland security companies"
Joe Bacchus, The Daily Record
(March 8, 2005)
Maryland and Israel are starting a year-long homeland security
business development program that officials hope will increase
the state’s role in the global economy and allow Maryland
to reap the benefits of Israel’s technology industry.
The third in a series of business
development programs, called MarketReach America, begins today
with a reception held by Gov. Robert L. Ehrlich Jr. in Annapolis.
The program highlights Maryland’s commitment to the development
of “new high-tech products,” Ehrlich said in a prepared
statement.
The program will bring together
business leaders from Maryland and Israel in order to help Israeli
technology companies enter the U.S. market.
“This is all about partnerships, and connecting Israeli companies with
their Maryland counterparts,” said Henry Fawell, a spokesman for Ehrlich. “This
will pay dividends both economically and from a homeland security standpoint.”
This excerpt was taken from the The Daily Record, a publication of the Maryland
Department of Business & Economic Development.
|
|
| February 2005 |
"Lockheed backs MarketReach [America] program"
Zev Stub, The Jerusalem Post (February 15, 2005, p. 17
print edition)
"MarketReach America, a business
development program assisting
Israeli homeland security
companies with the commercialization
of their products and technologies
in the US, said Monday that
aerospace giant Locke heed
Martin has joined its list
of sponsors."
|
| |
"Lockheed aids Israeli cos in US homeland security
market"
Globes [online] (February 14, 2005)
"Israeli companies seeking to penetrate the US homeland security market
will now have the backing of Lockheed Martin (NYSE: LMT). The US aerospace giant
has announced that it will sponsor MarketReach America, a business development
program assisting Israeli homeland security companies with the commercialization
of their products and technologies in the US."
An article in Hebrew about Lockheed Martin's participation and sponsorship also
appeared in Bizportal's, "Lockheed Martin assists Israeli companies with
their marketing in the United States" (Hezi Sternlicht, February 14, 2005).
|
| |
Israel Line – Economic & Hi-Tech Briefs
Victor Chemtob (February 14,
2005)
"Israeli companies seeking
to penetrate the U.S. homeland
security market will now have
the backing of Lockheed Martin,
Globes reported. The U.S.
aerospace giant has announced
that it will sponsor MarketReach
America, a business development
program assisting Israeli
homeland security companies
with the commercialization
of their products and technologies
in the United States."
|
|
| December 2004 |
"Exporting our security know-how: From the Holy Land to the homeland"
Calev Ben-David, The Jerusalem Post (December 3, 2004 print edition)
"If there's one certain growth area for business in the United Stats in the coming years, it's homeland
security." (This article also appeared in the online edition on December 2, 2004, under the title "Cashing
in on security.")
|
| |
"Identifying Explosive Material — the Hottest Sector in Homeland Security"
Zuri Da'ar, Haaretz Online (Finance section) (December 1, 2004)
"So said Christopher Cushing, president of the American consulting
firm, The Commonwealth Group, at the Homeland Security Conference
[in Tel Aviv] today; the budget in the homeland security sector
in the United States will reach about $40 billion in 2005." (The
full article appeared in Hebrew.)
This article also appeared on The Marker online (in Hebrew).
|
| |
"Conference on the Subject of Homeland Security"
Press release that appeared on
the News First Class
service (December 1, 2004)
The full release appeared in Hebrew. More
...
|
|
| November 2004 |
"MarketReach: Suggestions for 6 Israeli companies on entering the U.S. market"
Shay Pauzner, Bizportal (November
23, 2004)
"The $400,000 program includes strategic development for entry
into the U.S. homeland security
market. As well, it seeks strategic partners for the Israeli companies." (The
full article appeared in Hebrew.) More
...
|
|
| October 2004 |
"Promoting Productivity in the Homeland Security Field in the American Market"
Gunim (October 2004)
"MarketReach America Homeland Security 2005, is an assistance fund for companies in the homeland
security field, for business development and strategy for
the American market." (The full article appeared in Hebrew.)
|
| |
Israel's Magshoe provides a step ahead in security solutions
David Brinn, Israel21c (October 31, 2004)
MarketReach America is featured at the end of this article about "Israeli
innovations that are interesting American homeland security officials
these days." More...
|
| |
Economic and High-Tech News
Israel Line (October 29, 2004)
"Six Israeli homeland security companies will be selected to participate in MarketReach
America Homeland Security 2005, a business cooperation and development program that advises
and assists Israeli homeland security companies with the commercialization of their products
and technologies for the U.S. market, GLOBES reported."
|
| |
"Six
Israeli cos will be selected to market HLS products in US"
Globes correspondent, Globes [online] (October 28, 2004)
"The Maryland/Israel Development Center and Israel-based Trendlines have launched a $400,000 marketing
program." More
...
|
| |
"400,000 fund for homeland security"
Ze'ev Stub,
The Jerusalem Post (October 28, 2004)
"Six Israeli homeland security companies will be selected to participate
in MarketReach America Homeland Security 2005, a $400,000 program
launched by the Maryland/Israel Development Center and Israel-based
Trendlines Group."
|
| |
Joint venture with Israel tackles homeland security
Baltimore Sun (October 26, 2004)
"A local initiative that helps Israeli companies break
into the U.S. market is expanding into the homeland security
arena. MarketReach America, operated by the Maryland/Israel Development
Center and Israel-based Trendlines Group, will work with six
businesses in that industry next year. The program includes a
week-long trip to the state to learn about business development
from local experts."
|
|
| July 2004 |
"Lighting the Way for Israeli Companies"
Sarah Bronson, Haaretz (July 30, 2004)
"The CEOs of six Israel-based information technology companies returned this week from a five-day conference in Baltimore, where they were given individualized training in penetrating the American marketplace through a new business development program." More ...
|
| |
MarketReach America Companies Prepare Road Shows
from BioIsrael (July 22, 2004)
The five MarketReach America Life Sciences 2004 participants — Andante Medical Devices, Chiasma, ETView, Multi Gene Vascular System, and SLP — are hard at work during the final stage of the three-stage business development program. More ...
|
| |
MarketReach America ICET 2004 Participants Announced
from Globes [online] (July 21, 2004)
Five Israeli start-up companies have been selected to participate in this year's MarketReach America program, Information, Communication and Electronic Technology (MarketReach America ICET). More ...
|
| |
Six Israeli Technology Companies Participate in Business Development and Strategy Program for the American Market
from Globes [online] (July 20, 2004)
This article is in Hebrew. More ...
|
| |
Six Israeli Companies Chosen for MarketReach America Program
from Biz Portal (July 19, 2004)
This article is in Hebrew. More ...
|
|
| June 2004 |
MarketReach America Life Sciences Baltimore Conference
by Naomi Alper, Senior Project Manager, The Trendlines Group
"Upon my return from the five-day MarketReach America life sciences conference in Baltimore, Maryland, it was hard to describe the experience without reviewing the factors that combined to make it a stellar experience: fantastic presenters, unbelievable location, excellent food, and beautiful weather. So what was it really like?" More ...
|
|
|
April 2004 |
Opening the Door to U.S. Market Maryland Agency Hopes to Help Five Israeli Firms
From Washington Jewish Week (April 22, 2004)
"SLP has been producing sensors for sleep disorders, such as apnea, for 12 years and has been distributing them to the American market through a Virginia company. Now, the firm wants to "present our own face" in the American market, Noam Hadas, president of the Tel Aviv-based life science company, said this week." More ...
|
|
|
March 2004 |
MarketReach America Life Sciences Participants;
Applications for ICET and Dual-use Technology
Program Open
MarketReach America, the new business development initiative aimed at assisting Israeli companies commercialize their product or technology in the U.S. market, has announced the successful applicants in the Life Sciences 2004 program. As the Life Sciences program gets underway, applications are being invited for the Information, Communication and Electronic Technology (ICET) and Dual-use Technology program. More ...
|
|
|
February 2004 |
5 Biotech Companies to Win USISTF Development Grants
from Globes [online] (February 17, 2004)
The US-Israel Science and Technology Foundation grants are part of the MarketReach America program. More ...
|
News of MarketReach America Companies
|
|
October 2004 |
SLP Inc.
SLP Inc., the U.S. subsidiary of SLP Ltd. (Life Sciences 2004) has appointed Ken Godish as vice president and general manager. More ...
|
| |
ETView
ETView, one of the Life Sciences 2004 companies, recently established a Training Division within the company. This division has developed the ET-Trainer, a training version of the company's advanced endotracheal tube. More ...
|
|
September 2004 |
Israel Aircraft Industries (Guardium Project)
The Lahav Division of Israel Aircraft Industries (IAI) has combined C4I (command, control, communication, computer, and intelligence) development and unmanned security vehicle technology to produce the sophisticated Guardium first responder solution for perimeter security. More ...
|
| |
Jetro Platforms
This ICET 2004 participating company announced a new version of its flagship product: Jetro CockpIT™ Enterprise Version 3.5. This version is targeted toward large enterprises. More ...
|
|
|
July 2004 |
SLP Ltd.
SLP (Life Sciences 2004) made its first shipment of its SleepStrip product to a major U.S. distributor. More ...
|
|
|
June 2004 |
Multi Gene Vascular Systems
MGVS completed a $4 million institutional round led by Tamir Fishman Venture Capital (TASE: TFVC) and Europe's Fantine Group and Ofer Brothers Hi-Tech. More ...
|
|
ETView
A Life Sciences 2004 participating company, ETView has developed an advanced endotracheal tube (ETT) that offers safe airway management in emergency medicine, anesthesia, and resuscitation. More ...
|
|
SLP Ltd.
SLP has received approval from the U.S. Food and Drug Administration for its BiteStrip™, a disposable device that aids in evaluating nocturnal bruxism (teeth grinding).
More ...
|
